Breast cancer treatment and cognitive functioning: current status and future challenges in assessment.
Castellon
Steven A
SA
Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA. scastell@ucla.edu
Silverman
Daniel H S
DH
Ganz
Patricia A
PA
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D001943:Breast Neoplasms / Q000188:drug therapy*; D017024:Chemotherapy, Adjuvant; D003072:Cognition Disorders / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D011877:Radionuclide Imaging; D020845:Selective Estrogen Receptor Modulators / Q000009:adverse effects; D013629:Tamoxifen / Q000009:adverse effects
D000970:Antineoplastic Agents; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen